Classical Hallucinogens As Antidepressant Drugs: A Cautionary Approach
- PMID: 35469569
- PMCID: PMC10193763
- DOI: 10.2174/1570159X20666220425133824
Classical Hallucinogens As Antidepressant Drugs: A Cautionary Approach
Conflict of interest statement
The authors declare no conflict of interest, financial or otherwise.
References
-
- Gasser P., Holstein D., Michel Y., Doblin R., Yazar-Klosinski B., Passie T., Brenneisen R. Safety and efficacy of lysergic acid diethylamide-assisted psychotherapy for anxiety associated with life-threatening diseases. J. Nerv. Ment. Dis. 2014;202(7):513–520. doi: 10.1097/NMD.0000000000000113. - DOI - PMC - PubMed
-
- Griffiths R.R., Johnson M.W., Carducci M.A., Umbricht A., Richards W.A., Richards B.D., Cosimano M.P., Klinedinst M.A. Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: A randomized double-blind trial. J. Psychopharmacol. 2016;30(12):1181–1197. doi: 10.1177/0269881116675513. - DOI - PMC - PubMed
-
- Ross S., Bossis A., Guss J., Agin-Liebes G., Malone T., Cohen B., Mennenga S.E., Belser A., Kalliontzi K., Babb J., Su Z., Corby P., Schmidt B.L. Rapid and sustained symptom reduction following psilocybin treatment for anxiety and depression in patients with life-threatening cancer: A randomized controlled trial. J. Psychopharmacol. 2016;30(12):1165–1180. doi: 10.1177/0269881116675512. - DOI - PMC - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials